We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Graham Holdings Company
GHC
$4.92B
| $734K | ﹤0.01% |
1,223
| – | – |
|
752
iShares MSCI USA Quality Factor ETF
QUAL
$45.6B
| $731K | ﹤0.01% |
9,827
+697
| +8% | +$51.4K |
|
753
Quest Diagnostics
DGX
$25.2B
| $720K | ﹤0.01% |
6,485
-125
| -2% | -$13.2K |
|
754
Cboe Global Markets
CBOE
$29.8B
| $718K | ﹤0.01% |
7,855
| – | – |
|
755
Vail Resorts
MTN
$5.13B
| $718K | ﹤0.01% |
3,540
+130
| +4% | +$26.2K |
|
|
RMT
756
Royce Micro-Cap Trust
RMT
$745M
| $716K | ﹤0.01% |
82,802
-6,000
| -7% | -$51.5K |
|
|
TIF
757
DELISTED
Tiffany & Co.
TIF
| $715K | ﹤0.01% |
7,620
+48
| +0.6% | +$4.41K |
|
758
Voya Financial
VOYA
$8.78B
| $713K | ﹤0.01% |
19,333
+207
| +1% | +$7.53K |
|
759
BioMarin Pharmaceuticals
BMRN
$11.4B
| $711K | ﹤0.01% |
7,829
| – | – |
|
760
Baidu
BIDU
$36.5B
| $710K | ﹤0.01% |
3,968
-272
| -6% | -$49.3K |
|
761
CF Industries
CF
$19.5B
| $710K | ﹤0.01% |
+25,397
| New | +$700K |
|
762
Howard Hughes
HHH
$3.92B
| $703K | ﹤0.01% |
6,006
-372
| -6% | -$44K |
|
763
Wolverine World Wide
WWW
$1.51B
| $702K | ﹤0.01% |
25,097
+6,495
| +35% | +$164K |
|
|
KAMN
764
DELISTED
Kaman Corp
KAMN
| $701K | ﹤0.01% |
14,052
+1,788
| +15% | +$87K |
|
765
Teleflex
TFX
$5.81B
| $690K | ﹤0.01% |
3,322
-50
| -1% | -$10K |
|
766
Emcor
EME
$34.2B
| $685K | ﹤0.01% |
10,483
| – | – |
|
767
Ross Stores
ROST
$74.5B
| $685K | ﹤0.01% |
11,863
+5,656
| +91% | +$353K |
|
768
Exponent
EXPO
$2.91B
| $682K | ﹤0.01% |
23,404
| – | – |
|
769
IMAX
IMAX
$2.42B
| $679K | ﹤0.01% |
30,854
-71,157
| -70% | -$2M |
|
|
KG
770
Kestrel Group
KG
$71.3M
| $674K | ﹤0.01% |
3,034
+2,479
| +447% | +$579K |
|
771
McKesson
MCK
$96.5B
| $673K | ﹤0.01% |
4,087
-195
| -5% | -$29.6K |
|
772
Bio-Techne
TECH
$11.2B
| $666K | ﹤0.01% |
22,684
+272
| +1% | +$7.43K |
|
773
iShares MSCI USA Min Vol Factor ETF
USMV
$23B
| $665K | ﹤0.01% |
13,590
-1,798
| -12% | -$87.6K |
|
774
Alpha Architect US Quantitative Value ETF
QVAL
$563M
| $662K | ﹤0.01% |
25,934
| – | – |
|
|
ACBI
775
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $662K | ﹤0.01% |
+34,861
| New | +$657K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.